Fine specificity analysis of autoantibodies to T cell receptor CDR1 segments in rheumatoid arthritis.
Landsperger
W J
WJ
Baxter Biotech Hyland Division, Duarte, California 91010, USA.
Schluter
S F
SF
Garza
A
A
Yocum
D E
DE
Marchalonis
J J
JJ
D000888:Antibodies, Anti-Idiotypic / Q000276:immunology; D000918:Antibody Specificity; D001172:Arthritis, Rheumatoid / Q000276:immunology* / Q000628:therapy; D001323:Autoantibodies / Q000276:immunology*; D006801:Humans; D007135:Immunoglobulin Variable Region / Q000276:immunology*; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007167:Immunotherapy; D010446:Peptide Fragments / Q000276:immunology; D011948:Receptors, Antigen, T-Cell / Q000276:immunology*
D000888:Antibodies, Anti-Idiotypic; D001323:Autoantibodies; D007135:Immunoglobulin Variable Region; D016756:Immunoglobulins, Intravenous; D010446:Peptide Fragments; D011948:Receptors, Antigen, T-Cell; C048844:anti-IgG; C044203:anti-IgM